2022
DOI: 10.1016/j.jsat.2021.108550
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 related substance use services policy changes: Policymaker perspectives on policy development & implementation

Abstract: Due to the COVID-19 pandemic, regulations for substance use services changed to accommodate stay-at-home orders and physical distancing guidelines. Methods: Using in-depth interviews (N = 14) and framework analysis, we describe how policymakers developed, adopted, and implemented regulations governing services for substance use disorders during COVID-19, and how policymakers' perceived the impacts of these regulations in New York State. Results: During the COVID-19 pandemic, policymakers shifted to more inclus… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 20 publications
(27 reference statements)
0
6
0
Order By: Relevance
“…Policymakers shifted to more inclusive approaches of co-production of recommendations. The barriers to adoption and implementation that emerged, as a result of the new regulations, included stigma, lack of integration, and overcriminalization [59]. All of the aforementioned affected negatively substance users, and the available help diminished.…”
Section: Addiction During Covid-19mentioning
confidence: 99%
“…Policymakers shifted to more inclusive approaches of co-production of recommendations. The barriers to adoption and implementation that emerged, as a result of the new regulations, included stigma, lack of integration, and overcriminalization [59]. All of the aforementioned affected negatively substance users, and the available help diminished.…”
Section: Addiction During Covid-19mentioning
confidence: 99%
“…We undertook this work to inform our understanding of the MOUD treatment context that was impacting several of our current studies with protocols that had been designed prior to the pandemic's start. Participant perspectives such as this are a recognized gap in the literature regarding OUD treatment changes during the COVID-19 pandemic [27].…”
mentioning
confidence: 99%
“…This value for take-home methadone flexibilities and reduced OTP visits is consistent with what has been reported in qualitative studies of other populations of people who use drugs in the US [ 92 95 ]. Policy makers and providers have also reported positive experiences with relaxing restrictions on take-home MOUD during the pandemic and have endorsed shifting towards “low threshold” policies and person-centered care [ 96 98 ]. However, stigma by some policymakers and providers continues to be a challenge to the adoption and implementation of such relaxed policies [ 98 , 99 ].…”
Section: Discussionmentioning
confidence: 99%